Veriti Management LLC United Therapeutics Corp Transaction History

Veriti Management LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$311.04 - $363.55 $96,111 - $112,336	309 Added 13.09%	2,669 $956,000
Q2 2024 Aug 02, 2024	BUY	$228.26 - $319.04 $57,749 - $80,717	253 Added 12.01%	2,360 $751,000
Q1 2024 Apr 19, 2024	BUY	$210.76 - $249.51 $122,240 - $144,715	580 Added 37.98%	2,107 $484,000
Q4 2023 Feb 05, 2024	BUY	$214.88 - $256.94 $40,182 - $48,047	187 Added 13.96%	1,527 $335,000
Q3 2023 Oct 27, 2023	SELL	$211.82 - $248.24 $165,007 - $193,378	-779 Reduced 36.76%	1,340 $302,000
Q2 2023 Jul 13, 2023	BUY	$205.19 - $232.99 $105,672 - $119,989	515 Added 32.11%	2,119 $467,000
Q1 2023 Apr 26, 2023	BUY	$212.99 - $276.17 $50,904 - $66,004	239 Added 17.51%	1,604 $359,000
Q4 2022 Jan 20, 2023	SELL	$205.95 - $280.43 $37,894 - $51,599	-184 Reduced 11.88%	1,365 $0
Q3 2022 Oct 26, 2022	BUY	$203.3 - $244.17 $7,522 - $9,034	37 Added 2.45%	1,549 $324,000
Q2 2022 Jul 18, 2022	BUY	$174.81 - $241.14 $23,424 - $32,312	134 Added 9.72%	1,512 $356,000
Q1 2022 Apr 11, 2022	BUY	$166.16 - $213.96 $18,942 - $24,391	114 Added 9.02%	1,378 $247,000
Q4 2021 Jan 19, 2022	SELL	$184.32 - $216.08 $2,396 - $2,809	-13 Reduced 1.02%	1,264 $273,000
Q3 2021 Oct 08, 2021	BUY	$179.86 - $214.88 $13,669 - $16,330	76 Added 6.33%	1,277 $236,000
Q2 2021 Jul 13, 2021	BUY	$170.47 - $211.93 $204,734 - $254,527	1,201 New	1,201 $215,000
Q1 2021 Apr 14, 2021	SELL	$153.94 - $174.85 $136,544 - $155,091	-887 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$101.87 - $151.79 $90,358 - $134,637	887 New	887 $135,000

681

42.2M

194K

298K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

Stay updated on Veriti Management LLC with notifications on news.